1 / 42

Alterations of Hormonal Regulation

Alterations of Hormonal Regulation. Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular response Circulating inhibitors * water-soluble hormones (not steroids – lipid-soluble).

Anita
Download Presentation

Alterations of Hormonal Regulation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Alterations of Hormonal Regulation Chapter 18

  2. Dysfunction • Initially described • Excessive – hypersecretion • Insufficient - hyposecretion • Today • Abnormal receptor function • Altered intracellular response • Circulating inhibitors * water-soluble hormones (not steroids – lipid-soluble)

  3. Alterations of the Hypothalamic – Pituitary System “interruption of the pituitary stalk” • Destructive lesions • Rupture after head injury • Surgical transaction • Stem tumor

  4. Alterations of the Hypothalamic-Pituitary System

  5. Diseases of the Posterior Pituitary • Syndrome of inappropriate anti-diuretic hormone secretion (SIADH) • Hypersecretion of ADH • Ectopically produced (small cell carcinoma) • Brain injury or infection (pulmonary disease) • Psychiatric/drugs • Water intoxication ( ↓Na+, hypo-osmolality)

  6. Diseases of the Posterior Pituitary • Diabetes insipidus • Insufficiency of ADH • Polyuria and polydipsia • Partial or total inability to concentrate urine • Neurogenic • Insufficient amounts of ADH • Nephrogenic • Inadequate response to ADH • Psychogenic

  7. Diseases of the Anterior Pituitary • Hypopituitarism – “spectrum” • Pituitary infarction • Sheehan syndrome ( pituitary necrosis) • Hemorrhage • Shock • Other: head trauma, infections and tumors

  8. Diseases of the Anterior Pituitary • Hypopituitarism • Panhypopituitarism • ACTH deficiency • TSH deficiency • FSH & LH deficiency • GH deficiency

  9. Diseases of the Anterior Pituitary • Hyperpituitarism • Commonly caused by a benign slow- growing pituitary adenoma • Manifestation • Headache and fatigue • Visual changes • Hyposecretion of neighboring anterior pituitary hormones

  10. Diseases of the Anterior Pituitary • Hypersecretion of growth hormone (GH) • Acromegaly • Hypersecretion of GH during adulthood • Gigantism • Hypersecretion of GH in children and adolescents

  11. Diseases of the Anterior Pituitary • Hypersecretion of growth hormone (GH)

  12. Diseases of the Anterior Pituitary • Hypersecretion of prolactin (most common) • Caused by prolactinoma • In females – amenorrhea, galactorrhea, hirsutism and osteopenia • In males – hypogonodism, erectile dysfunction, impaired libido, oligospermia and ↓ ejaculate volume

  13. Alterations of Thyroid Function • Hyperthyroidism • Thyrotoxicosis • Graves disease • Hyperthyroidism resulting from nodular thyroid disease • Goiter • Thyrotoxic crisis

  14. Alterations of Thyroid Function • Hyperthyroidism

  15. Alterations of Thyroid Function • Hyporthyroidism (most common) • Primary • Subacute thyroiditis • Autoimmune thyroiditis (Hashimoto disease) • Painless thyroiditis • Postpartum thyroiditis • Myxedema coma • Congenital • Thyroid carcinoma

  16. Hypothyroidism

  17. Alterations of Parathyroid Function • Hyperparathyroidism • Primary • Excess secretion of PTH from one or more parathyroid gland • Secondary • ↑ PTH 2° to a chronic disease

  18. Alterations of Parathyroid Function • Hypopararthyroidism • Abnormally low PTH levels • Usually caused by parathyroid damage in thyroid surgery

  19. Dysfunction of the Endocrine Pancreas Diabetes Mellitus “group of disorders characterized by glucose intolerance” • Diagnosis • Random glucose > 200 mg/dl • FBS > 126 mg/dl (8° fast) • 2 hour plasma glucose > 200 mg/dl (75 gram OGTT) • Pre-diabetes • IGT – impaired glucose tolerance - ↓ insulin • IFG – impaired fasting glucose - ↑ hepatic glucose output • Glycosylated hemoglobin – HbA1c • Goals • Maintain euglycemia, avoid hypoglycemia • Prevent severe cardiovascular and neurologic complications

  20. Dysfunction of the Endocrine Pancreas Diabetes Mellitus • Type 1 • Pancreatic atrophy and specific loss of beta cells • Macrophages, T and B – lymphocytes, and natural killer (NK) cells are present • Two types • Immune • Non-immune

  21. Type 1 Diabetes Mellitus • Genetic susceptibility – HLA-DR3 & DR 4 • Environmental Factors • Drugs • Nutritional intake • Viruses • Mumps, coxsackie, rubella, cytomegalovirus • Immunologically mediated destruction of beta cells • Beta cell autoantibodies • Antibodies to insulin • Manifestations • Hyperglycemia, polydipsia, polyuria, polyphagia, weight loss, and fatigue – Table 18.5

  22. Type 2 Diabetes Mellitus • Non-insulin dependent • More common (90%) • Risk factors: obesity, family history, ethnic minority, puberty, female and metabolic syndrome • Cause • Unknown • Genetic susceptibility • Environmental factors • Cellular resistance to insulin • Obesity • ↓Beta cell response to plasma glucose • Abnormal glucagon secretion

  23. Type 2 Diabetes Mellitus • Pathophysiology • Combination • Excess nutrients (glucose/fat) → beta cell apoptosis • Obesity • Inflammatory cytokines • Obesity related (intra-abdominal fat) cytokines (adipokines) and ↑ FFA release • Major factors: insulin resistance and beta cell death Table 18-6 Manifestations

  24. Gestational Diabetes “glucose intolerance appears during pregnancy” • Risk factors • Family history • High-risk ethnic group • Advanced maternal age (> 25 years old) • Prior history • PCO syndrome • BMI > 25 kg/m2 • Past obstetrical complications - GD

  25. Acute Complications of Diabetes Mellitus • Hypoglycemia (45 to 50 mg/dl) • 90% Type 1 • Insulin shock or reaction • Diabetic ketoacidosis • Serious • ↓Insulin → ↑ counter regulatory hormones • Catecholamines, cortisol, glucagon, growth hormone • Peaks in adolescence

  26. Diabetic Ketoacidosis

  27. Acute Complications of Diabetes Mellitus • Hyperosmolar Hyperglycemic NonketoticSyndrome • Type 2 – elderly • Elevated serum glucose (500 mg/dl) • Severe dehydration (↑↑ serum osmotic pressure) → low blood volume ↓ BP • Ketosis – less common → insulin to # lipolysis and protein catabolism • Somogyi effect – counter regulatory hormone • Rebound hyperglycemia • Dawn phenomenon – GH • Early AM rise blood glucose

  28. Chronic Complications of Diabetes Mellitus • Hyperglycemia and non-enzymatic glycosylation • Hyperglycemia and the polyol pathway • Protein kinase C • Microvascular disease • Retinopathy • Diabetic nephropathy

  29. Chronic Complications of Diabetes Mellitus • Macrovascular disease (Type 2) • Coronary artery disease • Stroke • Peripheral artery disease • Diabetic neuropathies • Infection

  30. Alterations of Adrenal Function • Disorders of the adrenal cortex • Cushing disease • Excessive anterior pituitary secretion of ACTH • Cushing syndrome • Excessive level of cortisol regardless of cause

  31. Cushing Disease

  32. Cushing Disease

  33. Alterations of Adrenal Function • Disorders of the adrenal cortex • Hyperaldosteronism • Primary – Conn disease • Secondary

  34. Alterations of Adrenal Function • Disorders of the adrenal cortex • Adrenocortical hypofunction • Primary (Addison disease) • Idiopathic Addison disease • Secondary hypocortisolism

  35. Alterations of Adrenal Function • Disorders of the adrenal cortex • Hypersecretion of adrenal androgens and estrogens • Feminization • Virilization

  36. Virilization

  37. Alterations of Adrenal Function • Disorders of the adrenal medulla • Hyperfunction • Chromaffin cell tumor • Pheochromocytoma • Secretions of catecholamines on a continuous or episodic basis (norepinephrine)

More Related